Comparison of the Efficacy and Safety of Three Intravenous Immunoglobulin Brands in Pediatric Patients with Primary Immunodeficiency

被引：0

作者：

Engchuan, Vorapan ^{[1
]}

Yuenyongviwat, Araya ^{[2
]}

Sangsupawanich, Pasuree ^{[3
]}

机构：

[1] Prince Songkla Univ, Hat Yai, Thailand

[2] Prince Songkla Univ, Hat Yai, Thailand

[3] Prince Songkla Univ, Hat Yai, Thailand

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2016年 / 137卷 / 02期

关键词：

D O I：

10.1016/j.jaci.2015.12.872

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

737

引用

页码：AB226 / AB226

页数：1

共 50 条

[41] The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy [J].

Chapel, HM ;

Spickett, GP ;

Ericson, D ;

Engl, W ;

Eibl, MM ;

Bjorkander, J .

JOURNAL OF CLINICAL IMMUNOLOGY, 2000, 20 (02) :94-100

[42] The Comparison of the Efficacy and Safety of Intravenous Versus Subcutaneous Immunoglobulin Replacement Therapy [J].

H. M. Chapel ;

G. P. Spickett ;

D. Ericson ;

W. Engl ;

M. M. Eibl ;

J. Bjorkander .

Journal of Clinical Immunology, 2000, 20 :94-100

[43] The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy [J].

Björkander, J ;

Spickett, G ;

Ericson, D ;

Engl, W ;

Eibl, M ;

Chapel, H .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) :S174-S175

[44] EFFICACY OF A NEW INTRAVENOUS IMMUNOGLOBULIN PREPARATION IN PRIMARY IMMUNODEFICIENT PATIENTS [J].

OCHS, HD ;

LEE, ML ;

FISCHER, SH ;

KINGDON, HS ;

WEDGWOOD, RJ .

CLINICAL THERAPEUTICS, 1987, 9 (05) :512-522

[45] Safety and Efficacy of Home-Based Subcutaneous Immunoglobulin G in Elderly Patients with Primary Immunodeficiency Diseases [J].

Stein, Mark R. ;

Koterba, Alan ;

Rodden, Linda ;

Berger, Melvin .

POSTGRADUATE MEDICINE, 2011, 123 (05) :186-193

[46] Erratum to: Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases [J].

Hirokazu Kanegane ;

Kohsuke Imai ;

Masafumi Yamada ;

Hidetoshi Takada ;

Tadashi Ariga ;

Martin Bexon ;

Mikhail Rojavin ;

Wilson Hu ;

Midori Kobayashi ;

John-Philip Lawo ;

Shigeaki Nonoyama ;

Toshiro Hara ;

Toshio Miyawaki .

Journal of Clinical Immunology, 2014, 34 :520-520

[47] Efficacy and safety of a new immunoglobulin G product, Gammaplex®, in primary immunodeficiency diseases [J].

Moy, J. N. ;

Scharenberg, A. M. ;

Stein, M. R. ;

Suez, D. ;

Roberts, R. L. ;

Levy, R. J. ;

Ballow, M. ;

Fasano, M. B. ;

Dash, C. H. ;

Leach, S. J. .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 162 (03) :510-515

[48] Subcutaneous immunoglobulin 16.5% for the treatment of pediatric patients with primary antibody immunodeficiency [J].

Gupta, Sudhir ;

Kobayashi, Roger H. ;

Litzman, Jiri ;

Cherwin, Laurel ;

Hoeller, Sonja ;

Kreuwel, Huub .

EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (01) :7-17

[49] Individualized immunoglobulin treatment in pediatric patients with primary humoral immunodeficiency disease [J].

Patel, Niraj C. .

PEDIATRIC ALLERGY AND IMMUNOLOGY, 2018, 29 (06) :583-588

[50] Safety and Efficacy of PrivigenA®, a Novel 10% Liquid Immunoglobulin Preparation for Intravenous Use, in Patients with Primary Immunodeficiencies [J].

Stein, Mark R. ;

Nelson, Robert P. ;

Church, Joseph A. ;

Wasserman, Richard L. ;

Borte, Michael ;

Vermylen, Christiane ;

Bichler, Johann .

JOURNAL OF CLINICAL IMMUNOLOGY, 2009, 29 (01) :137-144

← 1 2 3 4 5 →